Development of prostate MR spectra analysis at high magnetic field for the purpose of evaluation of tumor aggressiveness

开发高磁场前列腺磁共振波谱分析以评估肿瘤侵袭性

基本信息

项目摘要

80 patients with prostate cancer were included in this study. However, we could compare between spectra data and biopsy results in 29 patients. The (choline + creatine)/citrate (CC/C) ratio was significantly higher in cancer than in healthy prostate. CC/C ratio and Gleason score were correlated strongly (r=0.686). CC/C ratio at higher magnetic field may predict the tumor aggressiveness.Development of spectral estimation method based on density matrix made it possible to measure T2-relaxation time of in-vivo citrate. The three-dimensional display software was developed in order to understand the location and volume of spectral abnormalities. This software will offer the important information to select treatments.
本研究纳入了80例前列腺癌患者。然而,我们可以比较29例患者的光谱数据和活检结果。前列腺癌患者的(胆碱+肌酸)/柠檬酸(CC/C)比值明显高于正常前列腺癌患者。CC/C比值与Gleason评分呈正相关(r=0.686)。高磁场下CC/C比值可预测肿瘤侵袭性。基于密度矩阵的光谱估计方法的发展使体内柠檬酸盐的t2弛豫时间的测量成为可能。为了了解光谱异常的位置和体积,开发了三维显示软件。该软件将为选择治疗方法提供重要信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAJI Yasushi其他文献

KAJI Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAJI Yasushi', 18)}}的其他基金

Prostate cancer in an aging society: What does MRI technology tell us about determining appropriate therapies?
老龄化社会中的前列腺癌:MRI 技术告诉我们如何确定适当的治疗方法?
  • 批准号:
    23591792
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prediction of aggressiveness of prostate cancer using MR spectroscopy at ultra-high magnetic field
使用超高磁场下的磁共振波谱预测前列腺癌的侵袭性
  • 批准号:
    15591275
  • 财政年份:
    2003
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 2.37万
  • 项目类别:
Functional role of Sec20, a BH3 and Secretory (Sec) domain protein, in neurons and its relevance to a motor neuron disease in Drosophila
Sec20(一种 BH3 和分泌 (Sec) 结构域蛋白)在神经元中的功能作用及其与果蝇运动神经元疾病的相关性
  • 批准号:
    10635856
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
皮质类固醇耐药性肠道GVHD的发病机制及防治
  • 批准号:
    10585851
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
  • 批准号:
    10585773
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5
与 SLC13A5 相关的柠檬酸转运蛋白紊乱的遗传和功能机制
  • 批准号:
    10651203
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Molecular mechanisms mediating the soft tissue attachment to teeth
介导软组织附着到牙齿的分子机制
  • 批准号:
    10838302
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Role of AMPK in melanoma brain metastasis
AMPK 在黑色素瘤脑转移中的作用
  • 批准号:
    10927688
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration
代谢和表观遗传调控是转分化和血管再生的结合体
  • 批准号:
    10905167
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
用于肾结石的组成型草酸盐生物降解枯草芽孢杆菌
  • 批准号:
    10740242
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Metabolic vulnerabilities in cancers with impaired TCA cycle activity
TCA 循环活性受损的癌症的代谢脆弱性
  • 批准号:
    10750296
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了